How to buy Viveve Medical stock - 14 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Viveve Medical stock

Own Viveve Medical stock in just a few minutes.

Viveve Medical, Inc is a medical devices business based in the US. Viveve Medical shares (VIVE) are listed on the NASDAQ and all prices are listed in US Dollars. Viveve Medical employs 42 staff and has a trailing 12-month revenue of around USD$5.5 million.

How to buy shares in Viveve Medical

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Viveve Medical. Find the stock by name or ticker symbol: VIVE. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Viveve Medical reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Viveve Medical, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Viveve Medical. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Viveve Medical share price

Use our graph to track the performance of VIVE stocks over time.

Viveve Medical shares at a glance

Information last updated 2021-04-09.
52-week rangeUSD$2.54 - USD$8
50-day moving average USD$3.3449
200-day moving average USD$4.3844
Wall St. target priceUSD$9.63
PE ratio 0.0266
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-113.927

Buy Viveve Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Viveve Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Viveve Medical under- or over-valued?

Valuing Viveve Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Viveve Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Viveve Medical's P/E ratio

Viveve Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Viveve Medical shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Viveve Medical financials

Revenue TTM USD$5.5 million
Gross profit TTM USD$296,000
Return on assets TTM -53.02%
Return on equity TTM -183.29%
Profit margin 0%
Book value $3.212
Market capitalisation USD$32 million

TTM: trailing 12 months

Shorting Viveve Medical shares

There are currently 2.1 million Viveve Medical shares held short by investors – that's known as Viveve Medical's "short interest". This figure is 0.3% up from 2.1 million last month.

There are a few different ways that this level of interest in shorting Viveve Medical shares can be evaluated.

Viveve Medical's "short interest ratio" (SIR)

Viveve Medical's "short interest ratio" (SIR) is the quantity of Viveve Medical shares currently shorted divided by the average quantity of Viveve Medical shares traded daily (recently around 1.3 million). Viveve Medical's SIR currently stands at 1.62. In other words for every 100,000 Viveve Medical shares traded daily on the market, roughly 1620 shares are currently held short.

However Viveve Medical's short interest can also be evaluated against the total number of Viveve Medical shares, or, against the total number of tradable Viveve Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Viveve Medical's short interest could be expressed as 0.2% of the outstanding shares (for every 100,000 Viveve Medical shares in existence, roughly 200 shares are currently held short) or 0.1995% of the tradable shares (for every 100,000 tradable Viveve Medical shares, roughly 200 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Viveve Medical.

Find out more about how you can short Viveve Medical stock.

Viveve Medical share dividends

We're not expecting Viveve Medical to pay a dividend over the next 12 months.

Have Viveve Medical's shares ever split?

Viveve Medical's shares were split on a 1:10 basis on 1 December 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Viveve Medical shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Viveve Medical shares which in turn could have impacted Viveve Medical's share price.

Viveve Medical share price volatility

Over the last 12 months, Viveve Medical's shares have ranged in value from as little as $2.54 up to $8. A popular way to gauge a stock's volatility is its "beta".

VIVE.US volatility(beta: 0.6)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Viveve Medical's is 0.5979. This would suggest that Viveve Medical's shares are less volatile than average (for this exchange).

Viveve Medical overview

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. The company was founded in 2005 and is headquartered in Englewood, Colorado.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site